Medicine: Too Many Drugs?

Some drugs that are aggressively peddled by pharmaceutical manufacturers may do more harm than good, and the facts that physicians need to know about them may be concealed for commercial reasons. These charges against the industry were made last week by two outspoken physicians, one with personal experience in the business, the other a university expert on its products.

Dr. Arthur Dale Console, 46, former medical research director for E. R. Squibb & Sons, told the Senate Antitrust Subcommittee (TIME, Dec. 21), chaired by Tennessee's Democrat Estes Kefauver, that many drugs of high price but low medicinal value are being foisted on...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!